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Regarding "Infected thrombophlebitis of the right 
internal jugular vein" 
To the Editors: 
Catheter-related septic central venous thrombosis can 
be an elusive diagnosis. The case described by Terada et al. 
(1996;24:1066-7) is convincing, but I must differ with the 
espoused surgical treatment. 
When I reviewed the literature in presenting a series of 
four patients, 1 it was clear that the majority of cases had 
been successfully treated with a prolonged course of intra- 
venous antibiotics and anticoagulation with heparin. Over 
the last decade, I have continued to accrue xperience with 
new cases at a rate of one per year, and in no instance has 
excision of a central vein proved necessary. As opposed to 
the management of peripheral septic phlebitis, for which 
excision is clearly the treatment of choice, sepsis in central 
veins seems to take a different course. The role ofheparin is
speculative, but it may act to halt incorporation ofbacteria 
into fresh, unorganized thrombus. Thrombectomy to de- 
bulk the septic lot has been reported 2 but does not appear 
to have an advantage over antibiotics and heparin alone. 
In the literature, there is no consensus on the duration 
ofheparin administration (I have used 1 to 2 weeks, stop- 
ping after the bacteremia has clearly ceased), on the utility 
of warfarin, and on the length of administration f antibi- 
otics (analogous to the treatment of endocarditis, I have 
advocated 6 weeks). In the otolaryngology literature, the 
analogous clinical problem is the Lemierre syndrome, sep- 
tic jugular thrombosis originating in an oropharyngeal 
infection, for which antibiotics are the primary treatment. 3 
In the neurology/neurosurgery literature, septic dural si- 
nus thrombosis also primarily treated without excision. 4 
In all of these syndromes, urgery should be reserved for 
persistent bacteremia despite anticoagulation a d intrave- 
nous antibiotics and where there is no evidence that endo- 
carditis is present, s 
Jeffrey L. Kaufman, MD 
Division of Vascular Surgery 
Baystate Medical Center 
759 Chestnut St. 
Springfield, MA 01199 
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24/41/80992 
Reply 
To the Editors: 
We appreciate he opportunity orespond to Dr. Kauf- 
man's letter. 
Our case was a rare situation. First, bacteremia devel- 
oped 4 weeks after the catheter was removed. The throm- 
bus was already organized. The organized thrombus was 
infected and contained purulent pus. Second, methicillin- 
resistant Staphylococcus aureus bacteremia was not con- 
trolled by vancomycin travenously. In a report by Raad et 
al., 1 of the 12 patients who had septic thrombosis caused 
by S. aureus, deep-seated infections (septic emboli, endo- 
carditis, meningitis, and abscess) developed infive patients. 
Heparin may be important in halting the extension of 
septic thrombus and the incorporation of bacteria into 
fresh, unorganized thrombus, as Dr. Kaufman mentions. 
We have no supporting data; however, we do not believe 
that intravenous vancomycin could penetrate an organized 
and infected thrombus, as in our case. 
We agree with Kaufman et al. 2 that catheter removal, 
anticoagulation, and a long course of appropriate intrave- 
nous antibiotics are the initial therapy in patients who have 
fresh septic entral venous thrombosis. We greatly appreci- 
ate Dr. Kaufman's commenting on our article. 
Yasushi Terada, MD 
Department ofCardiovascular Surgery 
Institute of Clinical Medicine 
University of Tsukuba 
Tsukuba-shi 
Ibaraki-ken 305, Japan 
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Prospective randomized trials of carotid 
endarterectomy with primary closure and patch 
reconstruction: The problem is power 
To the Editors: 
In a recent report hat compared primary closure with 
three patch reconstruction materials (AbuRahma et al., J 
Vasc Surg 1996;24:998-1007), the authors state in the 
methods ection that the statistical tests may be underpow- 
ered. No further consideration is given to the possible 
effects of low statistical power in discussing the results or 
making recommendations. With the exception of early 
residual or restenosis -50%, many of the multiple compar- 
isons of primary closure with patching flirt with the usual 
